{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:40:19Z","timestamp":1793248819038,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002642","name":"Korea University","doi-asserted-by":"publisher","award":["K1715341"],"award-info":[{"award-number":["K1715341"]}],"id":[{"id":"10.13039\/501100002642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002642","name":"Korea University","doi-asserted-by":"publisher","award":["K1715341"],"award-info":[{"award-number":["K1715341"]}],"id":[{"id":"10.13039\/501100002642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002642","name":"Korea University","doi-asserted-by":"publisher","award":["K1715341"],"award-info":[{"award-number":["K1715341"]}],"id":[{"id":"10.13039\/501100002642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002642","name":"Korea University","doi-asserted-by":"publisher","award":["K1715341"],"award-info":[{"award-number":["K1715341"]}],"id":[{"id":"10.13039\/501100002642","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea University Sejong Future Research Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Zika virus (ZIKV) is a mosquito-borne member of the <jats:italic>Flaviviridae<\/jats:italic> family. ZIKV infection has been associated with neurological complications such as microcephaly in newborns and Guillain-Barr\u00e9 syndrome in adults; thus, therapeutic agents are urgently needed. Statins are clinically approved for lowering cholesterol levels to prevent cardiovascular disease but have shown potential as antiviral drugs. In this study, we explored the possibility of utilizing statins as anti-ZIKV drugs. We found that, generally, lipophilic statins (atorvastatin, cerivastatin, fluvastatin, lovastatin, mevastatin, and simvastatin) could reduce ZIKV production <jats:italic>in vitro<\/jats:italic> and result in smaller foci of infection. Time-of-drug-addition assay revealed that early treatment with statins is more beneficial than late treatment; however, statins could not completely inhibit the entry stage of ZIKV infection. Furthermore, individual lipophilic statins differed in anti-ZIKV capacity, with fluvastatin being the most efficient at low concentrations. Taken together, this study shows that statins or their derivatives have the potential to be used as anti-ZIKV therapeutic agents.<\/jats:p>","DOI":"10.1038\/s41598-019-47956-1","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T10:02:56Z","timestamp":1565172176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Lipophilic statins inhibit Zika virus production in Vero cells"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1437-9069","authenticated-orcid":false,"given":"Erica","family":"Espa\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Hyun","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1495-488X","authenticated-orcid":false,"given":"Eun-Jung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daesub","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9070-341X","authenticated-orcid":false,"given":"Chong-Kil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"key":"47956_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00705-006-0903-z","volume":"152","author":"G Kuno","year":"2007","unstructured":"Kuno, G. & Chang, G. J. Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch. Virol. 152, 687\u2013696 (2007).","journal-title":"Arch. Virol."},{"key":"47956_CR2","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","volume":"360","author":"MR Duffy","year":"2009","unstructured":"Duffy, M. R. et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. New Engl. J. Med. 360, 2536\u20132543 (2009).","journal-title":"New Engl. J. Med."},{"key":"47956_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jcv.2014.12.005","volume":"63","author":"L Zammarchi","year":"2015","unstructured":"Zammarchi, L. et al. Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications. J. Clin. Virol. 63, 32\u201335 (2015).","journal-title":"J. Clin. Virol."},{"key":"47956_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0035-9203(52)90043-6","volume":"46","author":"GWA Dick","year":"1952","unstructured":"Dick, G. W. A. Zika virus (II). Pathogenicity and physical properties. Trans. R. Soc. Trop. Med. Hyg. 46, 521\u2013534 (1952).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"47956_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/CMR.00072-15","volume":"29","author":"D Musso","year":"2016","unstructured":"Musso, D. & Gubler, D. J. Zika Virus. Clin. Microbiol. Rev. 29, 487\u2013524 (2016).","journal-title":"Clin. Microbiol. Rev."},{"key":"47956_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1126\/science.aaf5036","volume":"352","author":"NR Faria","year":"2016","unstructured":"Faria, N. R. et al. Zika virus in the Americas: early epidemiological and genetic findings. Science 352, 345\u2013349 (2016).","journal-title":"Science"},{"key":"47956_CR7","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1056\/NEJMoa1602412","volume":"375","author":"P Brasil","year":"2016","unstructured":"Brasil, P. et al. Zika virus infection in pregnant women in Rio de Janeiro. New Engl. J. Med. 375, 2321\u20132334 (2016).","journal-title":"New Engl. J. Med."},{"key":"47956_CR8","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1056\/NEJMoa1601824","volume":"374","author":"RW Driggers","year":"2016","unstructured":"Driggers, R. W. et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. New Engl. J. Med. 374, 2142\u20132151 (2016).","journal-title":"New Engl. J. Med."},{"key":"47956_CR9","doi-asserted-by":"publisher","first-page":"e0005869","DOI":"10.1371\/journal.pntd.0005869","volume":"11","author":"AR Styczynski","year":"2017","unstructured":"Styczynski, A. R. et al. Increased rates of Guillain-Barr\u00e9 syndrome associated with Zika virus outbreak in the Salvador metropolitan area, Brazil. PLoS Negl. Trop. Dis. 11, e0005869, https:\/\/doi.org\/10.1371\/journal.pntd.0005869 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"47956_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bjid.2018.02.005","volume":"22","author":"L Barbi","year":"2018","unstructured":"Barbi, L., Coelho, A. V. C., Alencar, L. C. Ad & Crovella, S. Prevalence of Guillain-Barr\u00e9 syndrome among Zika virus infected cases: a systematic review and meta-analysis. Braz J Infect Dis 22, 137\u2013141 (2018).","journal-title":"Braz J Infect Dis"},{"key":"47956_CR11","first-page":"73","volume":"91","author":"World Health Organization (WHO)","year":"2016","unstructured":"World Health Organization (WHO). Zika virus infection: global update on epidemiology and potentially associated clinical manifestations. Wkly Epidemiol Rec 91, 73\u201381 (2016).","journal-title":"Wkly Epidemiol Rec"},{"key":"47956_CR12","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0024-3205(99)00199-X","volume":"65","author":"MH Moghadasian","year":"1999","unstructured":"Moghadasian, M. H. Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Life Sci. 65, 1329\u20131337 (1999).","journal-title":"Life Sci."},{"key":"47956_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1124\/pr.111.004994","volume":"64","author":"P Gazzerro","year":"2012","unstructured":"Gazzerro, P. et al. Pharmacological actions of statins: a critical appraisal in the management of cancer. Pharmacol. Rev. 64, 102\u2013146 (2012).","journal-title":"Pharmacol. Rev."},{"key":"47956_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24248-8","volume":"8","author":"C-S Chu","year":"2018","unstructured":"Chu, C.-S. et al. Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis. Sci Rep 8, 5804, https:\/\/doi.org\/10.1038\/s41598-018-24248-8 (2018).","journal-title":"Sci Rep"},{"key":"47956_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cmet.2015.05.022","volume":"22","author":"A Roy","year":"2015","unstructured":"Roy, A. et al. HMG-CoA reductase inhibitors bind to PPAR\u03b1 to upregulate neurotrophin expression in the brain and improve memory in mice. Cell Metab 22, 253\u2013265 (2015).","journal-title":"Cell Metab"},{"key":"47956_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1474-4422(17)30113-8","volume":"16","author":"D Chan","year":"2017","unstructured":"Chan, D. et al. Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial. Lancet Neurol 16, 591\u2013600 (2017).","journal-title":"Lancet Neurol"},{"key":"47956_CR17","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/SMJ.0b013e3181f0c6b4","volume":"103","author":"MR Andrus","year":"2010","unstructured":"Andrus, M. R. & East, J. Use of statins in patients with chronic Hepatitis C. Southern Medical Journal 103, 1018\u20131024 (2010).","journal-title":"Southern Medical Journal"},{"key":"47956_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000321892","volume":"54","author":"M Mart\u00ednez-Gutierrez","year":"2011","unstructured":"Mart\u00ednez-Gutierrez, M., Castellanos, J. E. & Gallego-G\u00f3mez, J. C. Statins reduce dengue virus production via decreased virion assembly. Intervirology 54, 202\u2013216 (2011).","journal-title":"Intervirology"},{"key":"47956_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1155\/2014\/872370","volume":"2014","author":"P Mehrbod","year":"2014","unstructured":"Mehrbod, P., Omar, A. R., Hair-Bejo, M., Haghani, A. & Ideris, A. Mechanisms of action and efficacy of statins against influenza. Biomed Res Int 2014, 8, https:\/\/doi.org\/10.1155\/2014\/872370 (2014).","journal-title":"Biomed Res Int"},{"key":"47956_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3892\/ijmm.2014.1761","volume":"34","author":"P Mehrbod","year":"2014","unstructured":"Mehrbod, P. et al. Simvastatin modulates cellular components in influenza A virus-infected cells. Int. J. Mol. Med. 34, 61\u201373 (2014).","journal-title":"Int. J. Mol. Med."},{"key":"47956_CR21","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.12688\/f1000research.9648.1","volume":"5","author":"Bruno S. Pascoalino","year":"2016","unstructured":"Pascoalino, B., Courtemanche, G., Cordeiro, M., Gil, L. & Freitas-Junior, L. Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library. F1000Res 5, https:\/\/doi.org\/10.12688\/f1000research.9648.1 (2016).","journal-title":"F1000Research"},{"issue":"12","key":"47956_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/v8120322","volume":"8","author":"Rodrigo Delvecchio","year":"2016","unstructured":"Delvecchio, R. et al. Chloroquine, an endocytosis blocking agent, inhibits Zika virus infection in different cell models. Viruses 8, https:\/\/doi.org\/10.3390\/v8120322 (2016).","journal-title":"Viruses"},{"key":"47956_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ebiom.2017.09.034","volume":"24","author":"C Li","year":"2017","unstructured":"Li, C. et al. Chloroquine, a FDA-approved drug, prevents Zika virus infection and its associated congenital microcephaly in mice. EBioMedicine 24, 189\u2013194, https:\/\/doi.org\/10.1016\/j.ebiom.2017.09.034 (2017).","journal-title":"EBioMedicine"},{"key":"47956_CR24","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1128\/JVI.00008-08","volume":"82","author":"GR Medigeshi","year":"2008","unstructured":"Medigeshi, G. R., Hirsch, A. J., Streblow, D. N., Nikolich-Zugich, J. & Nelson, J. A. West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of \u03b1v\u03b23 integrin. J. Virol. 82, 5212\u20135219 (2008).","journal-title":"J. Virol."},{"key":"47956_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1099\/vir.0.015255-0","volume":"91","author":"B Moesker","year":"2010","unstructured":"Moesker, B., Rodenhuis-Zybert, I. A., Meijerhof, T., Wilschut, J. & Smit, J. M. Characterization of the functional requirements of West Nile virus membrane fusion. J. Gen. Virol. 91, 389\u2013393 (2010).","journal-title":"J. Gen. Virol."},{"key":"47956_CR26","doi-asserted-by":"publisher","first-page":"7856","DOI":"10.1128\/JVI.77.14.7856-7862.2003","volume":"77","author":"K Stiasny","year":"2003","unstructured":"Stiasny, K., Koessl, C. & Heinz, F. X. Involvement of lipids in different steps of the flavivirus fusion mechanism. J. Virol. 77, 7856\u20137862 (2003).","journal-title":"J. Virol."},{"key":"47956_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1471-4159.2010.06951.x","volume":"115","author":"S Das","year":"2010","unstructured":"Das, S., Chakraborty, S. & Basu, A. Critical role of lipid rafts in virus entry and activation of phosphoinositide 3\u2032 kinase\/Akt signaling during early stages of Japanese encephalitis virus infection in neural stem\/progenitor cells. J. Neurochem. 115, 537\u2013549 (2010).","journal-title":"J. Neurochem."},{"key":"47956_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.plipres.2016.09.005","volume":"64","author":"MA Mart\u00edn-Acebes","year":"2016","unstructured":"Mart\u00edn-Acebes, M. A., V\u00e1zquez-Calvo, \u00c1. & Saiz, J.-C. Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses. Prog Lipid Res 64, 123\u2013137 (2016).","journal-title":"Prog Lipid Res"},{"key":"47956_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.chom.2007.09.003","volume":"2","author":"JM Mackenzie","year":"2007","unstructured":"Mackenzie, J. M., Khromykh, A. A. & Parton, R. G. Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe 2, 229\u2013239 (2007).","journal-title":"Cell Host Microbe"},{"key":"47956_CR30","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1128\/JVI.00117-08","volume":"82","author":"C-J Lee","year":"2008","unstructured":"Lee, C.-J., Lin, H.-R., Liao, C.-L. & Lin, Y.-L. Cholesterol effectively blocks entry of flavivirus. J. Virol. 82, 6470\u20136480 (2008).","journal-title":"J. Virol."},{"key":"47956_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.antiviral.2011.11.014","volume":"93","author":"MK Poh","year":"2012","unstructured":"Poh, M. K. et al. U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. Antiviral Res. 93, 191\u2013198 (2012).","journal-title":"Antiviral Res."},{"key":"47956_CR32","doi-asserted-by":"publisher","first-page":"e38202","DOI":"10.1371\/journal.pone.0038202","volume":"7","author":"J Pe\u00f1a","year":"2012","unstructured":"Pe\u00f1a, J. & Harris, E. Early dengue virus protein synthesis induces extensive rearrangement of the endoplasmic reticulum independent of the UPR and SREBP-2 pathway. PLoS One 7, e38202, https:\/\/doi.org\/10.1371\/journal.pone.0038202 (2012).","journal-title":"PLoS One"},{"key":"47956_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.virol.2009.03.025","volume":"389","author":"C Rothwell","year":"2009","unstructured":"Rothwell, C. et al. Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 389, 8\u201319 (2009).","journal-title":"Virology"},{"key":"47956_CR34","doi-asserted-by":"publisher","first-page":"e87412","DOI":"10.1371\/journal.pone.0087412","volume":"9","author":"M Martinez-Gutierrez","year":"2014","unstructured":"Martinez-Gutierrez, M., Correa-Londo\u00f1o, L. A., Castellanos, J. E., Gallego-G\u00f3mez, J. C. & Osorio, J. E. Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2. PLoS One 9, e87412, https:\/\/doi.org\/10.1371\/journal.pone.0087412 (2014).","journal-title":"PLoS One"},{"key":"47956_CR35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/hep.27835","volume":"62","author":"AA Butt","year":"2015","unstructured":"Butt, A. A. et al. Effect of addition of statins to antiviral therapy in hepatitis C virus\u2013infected persons: Results from ERCHIVES. Hepatology 62, 365\u2013374 (2015).","journal-title":"Hepatology"},{"key":"47956_CR36","doi-asserted-by":"publisher","unstructured":"Mohamed A. A. et al Statins added to chronic hepatitis C treatment: is it beneficial? Journal of Hepatology and Gastrointestinal Disorders 2, https:\/\/doi.org\/10.4172\/2475-3181.1000117 (2016).","DOI":"10.4172\/2475-3181.1000117"},{"key":"47956_CR37","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3892\/mmr.2016.5519","volume":"14","author":"OL Bryan-Marrugo","year":"2016","unstructured":"Bryan-Marrugo, O. L. et al. The anti-dengue virus properties of statins may be associated with alterations in the cellular antiviral profile expression. Mol Med Rep 14, 2155\u20132163 (2016).","journal-title":"Mol Med Rep"},{"key":"47956_CR38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1084\/jem.20040061","volume":"200","author":"G del Real","year":"2004","unstructured":"del Real, G. et al. Statins inhibit HIV-1 infection by down-regulating Rho activity. J Exp Med 200, 541\u2013547 (2004).","journal-title":"J Exp Med"},{"key":"47956_CR39","doi-asserted-by":"publisher","first-page":"e00660","DOI":"10.1128\/mBio.00660-18","volume":"9","author":"P Shrivastava-Ranjan","year":"2018","unstructured":"Shrivastava-Ranjan, P. et al. Statins suppress Ebola virus infectivity by interfering with glycoprotein processing. mBio 9, e00660\u201300618, https:\/\/doi.org\/10.1128\/mBio.00660-18 (2018).","journal-title":"mBio"},{"key":"47956_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.amjcard.2005.06.008","volume":"96","author":"RP Mason","year":"2005","unstructured":"Mason, R. P., Walter, M. F., Day, C. A. & Jacob, R. F. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions. Am J Cardiol 96, 11\u201323 (2005).","journal-title":"Am J Cardiol"},{"key":"47956_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.bbamem.2016.12.006","volume":"1859","author":"LF Galiullina","year":"2017","unstructured":"Galiullina, L. F. et al. Interaction of different statins with model membranes by NMR data. Biochim. Biophys. Acta 1859, 295\u2013300 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"47956_CR42","doi-asserted-by":"publisher","first-page":"III-50-III-57","DOI":"10.1161\/01.CIR.0000131519.15067.1f","volume":"109","author":"S Bellosta","year":"2004","unstructured":"Bellosta, S., Paoletti, R. & Corsini, A. Safety of statins. Circulation 109, III-50-III-57, https:\/\/doi.org\/10.1161\/01.CIR.0000131519.15067.1f (2004).","journal-title":"Circulation"},{"key":"47956_CR43","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1365-2125.2011.03907.x","volume":"72","author":"L Bj\u00f6rkhem-Bergman","year":"2011","unstructured":"Bj\u00f6rkhem-Bergman, L., Lindh, J. D. & Bergman, P. What is a relevant statin concentration in cell experiments claiming pleiotropic effects? Br. J. Clin. Pharmacol. 72, 164\u2013165 (2011).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"mar17 10","key":"47956_CR44","doi-asserted-by":"publisher","first-page":"h1035","DOI":"10.1136\/bmj.h1035","volume":"350","author":"B. T. Bateman","year":"2015","unstructured":"Bateman, B. T. et al. Statins and congenital malformations: cohort study. BMJ 350, https:\/\/doi.org\/10.1136\/bmj.h1035 (2015).","journal-title":"BMJ"},{"key":"47956_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.expneurol.2010.04.006","volume":"230","author":"Q Wang","year":"2011","unstructured":"Wang, Q. et al. Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Exp. Neurol. 230, 27\u201334 (2011).","journal-title":"Exp. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47956-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47956-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47956-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:25:29Z","timestamp":1671279929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47956-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["47956"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-47956-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,7]]},"assertion":[{"value":"10 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11461"}}